This inventor holds 4 USPTO granted patents. Top assignee: The Picower Institute for Medical Research. Active years: 1999.
Company Filing History:
Years Active: 1999
Title: Innovations by Inventor Yong Ming Li in Advanced Glycosylation Detection
Introduction
Yong Ming Li is a prominent inventor based in Fresh Meadows, NY, known for his significant contributions in the field of medical research. With a portfolio that boasts four patents, his work has emphasized the importance of detecting advanced glycosylation endproducts (AGEs), which are critical in understanding various diseases and disorders.
Latest Patents
Li's recent patents focus on innovative methods for detecting the presence of AGEs. One notable invention involves the unexpected discovery that certain antibacterial proteins, specifically lysozyme and lactoferrin, bind to AGEs with high affinity. This binding activity is noncompetitive with bacterial carbohydrates, laying the groundwork for novel diagnostic methods targeting diseases associated with elevated AGE levels. Furthermore, his inventions extend to compositions and devices designed for partitioning AGEs away from biological samples, enhancing the diagnostic capabilities in medical research.
Career Highlights
Yong Ming Li has established himself at the Picower Institute for Medical Research, where he continues to explore innovative approaches to medical diagnostics. His expertise in the interaction between antibacterial proteins and AGEs positions him as a leading figure in advancing our understanding of these critical biological markers.
Collaborations
Throughout his career, Li has collaborated with esteemed researchers such as Helen Vlassara and Anthony Cerami. These partnerships have been instrumental in advancing research on AGEs and their implications in health and disease, contributing to a stronger scientific community focused on improving medical outcomes.
Conclusion
In summary, Yong Ming Li’s innovative work and patents are paving the way for new diagnostic methods concerning advanced glycosylation endproducts. His contributions not only highlight the intersection of antibacterial proteins and diseases associated with AGEs but also reflect the importance of collaboration in scientific advancements. As researchers continue to build on his findings, the potential for improving healthcare outcomes becomes ever more promising.